FENTANYL CITRATE
- Product NDC
- 52533-025
- 11-digit product format
- 525330025
- Labeler code
- 52533
- Product ID
- 52533-025_c96e60ea-3961-42b4-805f-320321fb9eda
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Fentanyl Citrate
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Cantrell Drug Company
- Marketing category
- UNAPPROVED DRUG OTHER
- Marketing start
- 2014-08-21
- Marketing end
- 0000-00-00
- Substance
- FENTANYL CITRATE
- Active strength
- 20 ug/mL
- Pharmacologic classes
- Full Opioid Agonists [MoA],Opioid Agonist [EPC]
- DEA schedule
- CII
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 52533-025-75 | Fentanyl Citrate | 100 mL in 1 BAG | INJECTION, SOLUTION | 100 | | 3 |
| 52533-025-05 | FENTANYL CITRATE | 30 mL in 1 VIAL, GLASS | INJECTION, SOLUTION | 30 | | 1 |
| 52533-025-10 | Fentanyl Citrate | 30 mL in 1 SYRINGE, GLASS | INJECTION, SOLUTION | 30 | | 1 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| Fentanyl Citrate | ACTIVE INGREDIENT | MUN5LYG46H | FENTANYL CITRATE INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 3 | |
| Fentanyl | ACTIVE MOIETY | UF599785JZ | FENTANYL CITRATE INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 3 | |
| Sodium Chloride | INACTIVE INGREDIENT | 451W47IQ8X | FENTANYL CITRATE INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 3 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | FENTANYL CITRATE INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 3 | |
| FENTANYL CITRATE | ACTIVE INGREDIENT | MUN5LYG46H | FENTANYL CITRATE INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 1 | |
| FENTANYL CITRATE | ACTIVE INGREDIENT | MUN5LYG46H | FENTANYL CITRATE INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 1 | |
| FENTANYL | ACTIVE MOIETY | UF599785JZ | FENTANYL CITRATE INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 1 | |
| FENTANYL | ACTIVE MOIETY | UF599785JZ | FENTANYL CITRATE INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 1 | |
| Sodium Chloride | INACTIVE INGREDIENT | 451W47IQ8X | FENTANYL CITRATE INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 1 | |
| Sodium Chloride | INACTIVE INGREDIENT | 451W47IQ8X | FENTANYL CITRATE INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 1 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | FENTANYL CITRATE INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 1 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | FENTANYL CITRATE INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 1 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 52533-025 | FENTANYL CITRATE INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 3 | Legacy NDC, 1 package rows | 20130515_f98ebc12-05ac-4777-9eb5-642fb8124b50.zip |
| 52533-025 | FENTANYL CITRATE INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 1 | Legacy NDC, 1 package rows | 20140813_f936818a-b0bd-4811-b9b8-3fa9620a7379.zip |
| 52533-025 | FENTANYL CITRATE INJECTION, SOLUTION [CANTRELL DRUG COMPANY] | 1 | Legacy NDC, 1 package rows | 20140821_9622cd81-1387-41c5-a42d-469d2e757629.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Status |
|---|
| 52533-025-05 | 52533002505 | 30 mL in 1 VIAL, GLASS | 30 ml | Historical |
| 52533-025-10 | 52533002510 | 30 mL in 1 SYRINGE, GLASS | 30 ml | Historical |
| 52533-025-75 | 52533002575 | 100 mL in 1 BAG | 100 ml | Historical |